Fifth Third Bancorp Humacyte, Inc. Transaction History
Fifth Third Bancorp
- $27.1 Billion
- Q4 2024
A detailed history of Fifth Third Bancorp transactions in Humacyte, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 950 shares of HUMA stock, worth $3,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
950
Previous 950
-0.0%
Holding current value
$3,144
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
172Shares Held
41MCall Options Held
553KPut Options Held
942K-
Black Rock Inc. New York, NY7.14MShares$23.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$18.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.61MShares$15.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA2.85MShares$9.43 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA2.14MShares$7.07 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $341M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...